[Corrigendum] Antiproliferative effects of imatinib mesylate on ZR‑75‑1 and MDA‑MB‑231 cell lines via PDGFR‑β, PDGF‑BB, c‑Kit and SCF expression
An interested reader drew to our attention that the above study appeared to contain a high level of overlap with an article by the same authors published in the journal Drug Design, Development and Therapy [Kadivar A, Kamalidehghan B, Akbari Javar H, Karimi B, Sedghi R and Noordin MI: Antiproliferat...
Saved in:
Main Authors: | Kadivar, Ali, Noordin, Mohamed Ibrahim, Aditya, Arya, Kamalidehghan, Behnam, Davoudi, Ehsan Taghizadeh, Sedghi, Reihaneh, Javar, Hamid Akbari |
---|---|
Format: | Article |
Published: |
Elsevier
2019
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/24150/ https://doi.org/10.3892/ijmm.2019.4119 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antiproliferative effects of imatinib mesylate on ZR‑75‑1 and MDA‑MB‑231 cell lines via PDGFR‑β, PDGF‑BB, c‑Kit and SCF expression
by: Kadivar, Ali, et al.
Published: (2018) -
Antiproliferation effect of imatinib mesylate on MCF7, T-47D tumorigenic and MCF 10A nontumorigenic breast cell lines via PDGFR-β, PDGF-BB, c-Kit and SCF genes
by: Kadivar, A., et al.
Published: (2017) -
Molecular basis of primary and secondary
resistance to imatinib mesylate
by: Abdul Aziz, Baba
Published: (2012) -
Imatinib mesylate in the treatment of chronic myeloid leukemia: a local experience
by: Bee, P.C., et al.
Published: (2006) -
An update on imatinib mesylate therapy in chronic myeloid leukaemia patients in a teaching hospital in Malaysia
by: Bee, P.C., et al.
Published: (2012)